[1]
Javaeed, A. and Ghauri, S.K. 2019. MCT4 has a potential to be used as a prognostic biomarker - a systematic review and meta-analysis. Oncology Reviews. 13, 2 (Jul. 2019). DOI:https://doi.org/10.4081/oncol.2019.403.